FDA approves and authorizes updated mRNA COVID-19 vaccines to better protect against currently circulating variants.| U.S. Food and Drug Administration
The US FDA gave the official thumbs up to the 2024-2025 updated COVID vaccines from Pfizer and Moderna that target the KP.2 variant of SARS-CoV-2 last week.| thosenerdygirls.substack.com